| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |